STAAR Surgical Co. Form 8-K Summary
Business Context and Reporting Period
STAAR Surgical Company (STAA) filed a Current Report on Form 8-K on April 8, 2026. The filing discloses preliminary financial results for the first quarter ended April 3, 2026, via a press release furnished as Exhibit 99.1. Full financial results for the quarter are expected to be reported in early May 2026.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the referenced press release (Exhibit 99.1) but are not detailed in the body of this Form 8-K.
Material Changes
No material changes versus the prior comparable period are described in the text of this filing. The document serves solely to announce the issuance of preliminary results.
Guidance, Outlook, and Management Commentary
Management, represented by Interim Co-Chief Executive Officer and Chief Financial Officer Deborah Andrews, indicated that full first-quarter financial results will be reported in early May 2026. The filing explicitly states that the information provided, including the press release, is not deemed "filed" for purposes of Section 18 of the Exchange Act and shall not be incorporated by reference into other filings.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific preliminary revenue and earnings figures.
- Monitor the company's announcement in early May 2026 for audited or full quarterly financial statements.
- Verify the role and tenure of Deborah Andrews as Interim Co-CEO and CFO.
- Confirm that the preliminary data is not subject to the liabilities of Section 18 of the Exchange Act as stated in the filing.